- Category Marryalyan
- DATE 25 Jan 2023
Exercise & Cancer Group
January 2023
This has been my first full year as Chair of the Exercise & Cancer Group, and I have really enjoyed the opportunity to work with such a diverse and dynamic group of health professionals all motivated for promotion of exercise in cancer care. Having spent the first half of the year in Memphis, US, on a Fulbright Fellowship, I did my best with late night meetings to stay in touch with the Exercise & Cancer Executive Committee and other initiatives. Now that I’ve returned, I’m keen on building further in 2023.
There were some great highlights in 2022 including the first face-to-face COSA ASM in years, achievements by individuals and research groups, landmark publications and a changing of the guard in the Executive Committee.
Exercise & Cancer Group at the 2022 COSA Annual Scientific Meeting in Brisbane
How great was it to meet face to face at the 2022 COSA ASM in Brisbane this year! One of my conference highlights, which too was exercise-related, was the multi-disciplinary morning run along Brisbane river. We were represented by medical oncology, surgery, exercise physiology, psychology, and epidemiology. We hope to explore Melbourne’s running landscape in 2023!
The Exercise & Cancer Group was well represented at the conference. We hosted a really interactive AGM, which covered the group’s annual progress and future initiatives. It was a great forum for new members to interact. There were 10 excellent exercise-oncology oral presentations at the ASM, including:
- Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer - Yufan Wang
- The cancer exercise toolkit: giving exercise professionals online tools to bridge the evidence-practice gap - Amy Dennett
- Exercise across the lung cancer care continuum: an overview of systematic reviews - Lara Edbrooke
- Pre- and rehabilitation for people with lung cancer: current evidence and future directions - Lara Edbrooke
- Health behaviours of Indigenous and non-Indigenous cancer survivors living in regional and remote geographic areas of Australia - Elaina Elder-Robinson
- An individualised exercise intervention improves quality of life for people with multiple myeloma: the MyeEx randomised waitlist-controlled trial - Jennifer L Nicol
- Essential elements of optimal dietary and exercise referral practices for cancer survivors: Expert consensus for medical and nursing health professionals. - Ria Joseph
- The ECHO trial – exercise during chemotherapy for ovarian cancer - Rosa Spence
- Exercise and dietary intervention to improve the quality of life of women diagnosed with metastatic breast cancer - Marina Reeves
- Multimodal intervention for cachexia in advanced cancer patients undergoing chemotherapy. - Vickie Baracos
There were also 18 poster presentations and an EP in Breakfast session on Sarcopenia/Malnutrition.
Awards and achievements
There were some wonderful achievements among members of the Exercise & Cancer Group in 2022, well done to all! These are just a snapshot:
Dr Amy Dennett – Transdisciplinary Research for Energetics in Cancer Fellowship, Yale, US
A/Prof Nicolas Hart – NHMRC Investigator Grant, Cancer Survivorship
Dr Carolina Sandler – NSW Cancer Institute Fellowship, Cancer fatigue
Dr David Mizrahi - Fulbright Fellowship, St Jude Children’s Hospital, Memphis, US, Childhood cancer
A/Prof Tina Skinner – World Cancer Research Fund, Multiple Myeloma
I also wanted to acknowledge the fantastic research consistently coming out of leading Australian exercise oncology research hubs, including iHop (QLD), led by Prof Sandi Hayes, who recently recruited their 500th participant in the ECHO study (exercise RCT for ovarian cancer), and ECU (WA), led by Prof Rob Newton, who continue to lead the way in the implementation and delivery of exercise for Prostate and other cancers.
Research update
There have been numerous exciting new papers in 2022 by COSA members in Exercise-Oncology. This is a testament to the increasingly recognised role for prescribing exercise and supporting patients to become more physically active during and after treatment. Below is a small snapshot of recent articles:
- Nicolas Hart, Rob Newton, Prue Cormie - Exercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise Professionals – JCO Oncology Practice
- Stephen Foulkes, Steve Fraser - Exercise for the Prevention of Anthracycline-induced Functional Disability and Cardiac Dysfunction: The BReast Cancer Randomized EXercise InTervention (BREXIT) Study – Circulation
- Rosa Spence, Carolina Sandler, Sandi Hayes - A Randomised, Comparative, Effectiveness Trial Evaluating Low- versus High-Level Supervision of an Exercise Intervention for Women with Breast Cancer: The SAFE Trial - Cancers
Executive Committee Updates
We had a changing of the guard on the committee, including welcoming Dr Lina Pugliano (Medical oncologist), Dr Lara Edbrooke, Liz Pinkham (physiotherapists), Prof Rob Newton, A/Prof Steve Fraser, and Dr Kellie Toohey (Exercise Physiologists). Thank you to former members for their years of service: Andrew Murnane, Lucy Bucci, Sharni Quinn, Morgan Atkinson, Dr Sara Wahlroos, Dr Elysia Thornton-Benko.
The Executive Committee welcomes any suggestions to improve the Group or to conduct initiatives, so we would love to hear from you.
David Mizrahi
Chair
Exercise & Cancer Group

Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 7 hours ago
The latest Survivorship eNews is out now! With working group updates, new COSA-endorsed resources, journal articles, COSA-IPOS 2025 key survivorship sessions & more. Check your inbox, visit
Read More >
COSAoncology 7 hours ago
Cancer Pharmacists Group Fellowship opportunity! COSA is offering an early career researcher mentorship, guidance and support to develop a COSA position statement on 'Documentation of Hypersensitivity Reactions to SACT'. Find out more
Read More >
COSAoncology 4 days ago
Congratulations @Joanne472 recipient of the 2025 Melanie Price Psycho-Oncology Award and Dr Sarah Ellis recipient of the 2025 Phyllis Butow New Investigator Award. Join us in recognising their achievements at COSA-IPOS 2025 in Adelaide in November.
Read More >
COSAoncology 12 days ago
Congrats Prof Gail Garvey AM recipient of 2025 Tom Reeve Award for Outstanding Contribution to Cancer Care. Her work has contributed greatly to policy and practice changes to improve the outcomes of First Nation's people with cancer. Presentation & oration
Read More >
COSAoncology 19 days ago
Our August member newsletter is out now. Check your inbox for COSA news and updates – webinars, resources, opportunities, journal articles and events. Or log in and read it online anytime at
Read More >
COSAoncology 24 days ago
Earlybird closes in 1 week! Don't miss the exciting program and networking opportunities at #COSAIPOS2025 this November in beautiful Adelaide. With support from #Adelaide, @BizEventsAdl, @AdelaideCC. View the program
Read More >
COSAoncology 25 days ago
Join us for a collaborative webinar exploring nurse-led survivorship care models and their role in addressing pressures in the health system. Ideal for multidisciplinary cancer care teams looking to embed sustainable, outcomes-focused survivorship care.
Read More >
COSAoncology 26 days ago
In partnership with @CancerCouncilOz, we’re offering three grants up to AUD$3,300 to support Aboriginal and Torres Strait Islander delegates to attend #COSAIPOS2025 in Adelaide this November. Applications close in one week. Apply now
Read More >
COSAoncology one month ago
Are you joining us in Adelaide in November for #COSAIPOS2025? Earlybird discounts end in 2 weeks. So grab the opportunity today to connect with new and familiar faces for an exciting multidisciplinary, interdisciplinary and transdisciplinary program.
Read More >
COSAoncology one month ago
New Survivorship Fellowship opportunity. COSA is offering an early career researcher mentorship, guidance and support to lead a project mapping survivorship in state, territory and national cancer plans. Find out more
Read More >